MedFluid. Co. Ltd
CES2021-014 MedFluid.mp4
MedFluid Co. Ltd.
MedFluid is committed to develop microfluidic platforms for rapid detection and screening tools of disease diagnosis and supporting precise medical prescriptions to improve the health and well-being of patients.
fAST
Our product, fAST, automates both genotype and phenotype detections to identify bacteria within 1.5 hours and the multiple antibiotics combination test within 5 hours. fAST / Automated bacteria identification and multiple antibiotics combination testMedFluid uses microfluidics as our core technique to develop an in vitro diagnostic (IVD) system, fAST, to support the precision medicine of antibiotics.
Digital Health
Startups
MedFluid Co. Ltd.
MedFluid is committed to develop microfluidic platforms for rapid detection and screening tools of disease diagnosis and supporting precise medical prescriptions to improve the health and well-being of patients.